Trial Profile
Efficacy of nivolumab in advanced hepatocellular carcinoma (HCC) and Child Pugh B (CPB) cirrhosis : Retrospective case series
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2019
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 02 Jun 2019 Results published in the Cancer
- 22 Feb 2018 New trial record
- 20 Jan 2018 Results presented at the 2018 Gastrointestinal Cancers Symposium